Esperion Therapeutics Inc (ESPR)
1.905
-0.04
(-2.31%)
USD |
NASDAQ |
Apr 22, 16:00
1.905
0.00 (0.00%)
After-Hours: 20:00
Esperion Therapeutics Shareholders Equity (Quarterly): -454.99M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -454.99M |
| September 30, 2023 | -410.00M |
| June 30, 2023 | -371.98M |
| March 31, 2023 | -329.66M |
| December 31, 2022 | -323.78M |
| September 30, 2022 | -294.10M |
| June 30, 2022 | -291.70M |
| March 31, 2022 | -249.04M |
| December 31, 2021 | -196.94M |
| September 30, 2021 | -362.70M |
| June 30, 2021 | -304.31M |
| March 31, 2021 | -269.39M |
| December 31, 2020 | -96.13M |
| September 30, 2020 | 8.96M |
| June 30, 2020 | 85.49M |
| March 31, 2020 | -50.25M |
| December 31, 2019 | 19.95M |
| September 30, 2019 | 68.51M |
| June 30, 2019 | 129.33M |
| March 31, 2019 | 175.01M |
| December 31, 2018 | 79.12M |
| September 30, 2018 | 131.74M |
| June 30, 2018 | 175.92M |
| Date | Value |
|---|---|
| March 31, 2018 | 214.14M |
| December 31, 2017 | 244.69M |
| September 30, 2017 | 278.10M |
| June 30, 2017 | 154.11M |
| March 31, 2017 | 192.42M |
| December 31, 2016 | 228.60M |
| September 30, 2016 | 254.18M |
| June 30, 2016 | 267.96M |
| March 31, 2016 | 277.76M |
| December 31, 2015 | 287.26M |
| September 30, 2015 | 296.48M |
| June 30, 2015 | 305.46M |
| March 31, 2015 | 314.43M |
| December 31, 2014 | 133.55M |
| September 30, 2014 | 50.22M |
| June 30, 2014 | 58.91M |
| March 31, 2014 | 67.04M |
| December 31, 2013 | 74.09M |
| September 30, 2013 | 83.23M |
| June 30, 2013 | 12.89M |
| March 31, 2013 | 19.74M |
| December 31, 2012 | -17.39M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-454.99M
Minimum
Dec 2023
129.33M
Maximum
Jun 2019
-194.35M
Average
-269.39M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
| United Therapeutics Corp | 5.985B |
| Masimo Corp | 1.365B |
| Heron Therapeutics Inc | -33.97M |
| Aldeyra Therapeutics Inc | 119.80M |
| Ocugen Inc | 40.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 205.80M |
| Total Liabilities (Quarterly) | 660.79M |
| Debt to Equity Ratio | -0.5749 |
| Current Ratio | 1.287 |
| Net Debt Paydown Yield | -0.12% |